Internet Explorer and Edge browser users:
To download Word, Excel or PowerPoint files please right-click on the file you wish to download, and select 'Save target as...'

​Unlawful advertising of botulinum toxin injections

28 January 2020

 

The Committee of Advertising Practice and the Advertising Standards Agency (ASA), have launched a new campaign to tackle the unlawful advertising of botulinum toxin injections on social media.

 

Botulinum toxin injections, such as Botox, Vistabel, Dysport, Bocouture and Azzalure, are prescription only medicines and cannot be advertised to the public, even when they are to be administered by a registered healthcare professional.

 

Dentists should take immediate action to review any social media advertising and make any necessary changes. The ASA has issued guidance to support compliance, so take a look at this now if you advertise these products on social media.

 

After Friday 31 January, the ASA will be taking targeted enforcement action, which for those unwilling to comply, may include referral to the Medicines and Healthcare products Regulatory Agency (MHRA) or the General Dental Council (GDC).

 

BDA members can access our advice sheet on Botox and non-surgical cosmetic procedures.

 

BDA advisory services

Our advisory services team offers advice to BDA members on a huge range of issues, such as employment law, health and safety, the NHS, business support and regulatory inspections. We also provide employment representation, an associate contract-checking service, mediation services, tribunal support and consultancy services.

 

With each new member, our voice and our influence grows.

 

Add your voice, join today.